Aisling Capital Management’s Spruce Biosciences SPRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $948K | Hold |
|
|||||
|
2023
Q4 | $3.53M | Hold |
|
|||||
|
2023
Q3 | $2.72M | Hold |
|
|||||
|
2023
Q2 | $2.59M | Hold |
|
|||||
|
2023
Q1 | $2.66M | Hold |
|
|||||
|
2022
Q4 | $1.32M | Hold |
|
|||||
|
2022
Q3 | $1.65M | Hold |
|
|||||
|
2022
Q2 | $2.1M | Hold |
|
|||||
|
2022
Q1 | $2.42M | Hold |
|
|||||
|
2021
Q4 | $5.38M | Hold |
|
|||||
|
2021
Q3 | $7.25M | Hold |
|
|||||
|
2021
Q2 | $13.5M | Hold |
|
|||||
|
2021
Q1 | $20M | Hold |
|
|||||
|
2020
Q4 | $29.3M | Buy |
|